Bli medlem
Bli medlem

Du är här


Vitrolife AB (publ): Redeye: Resumes analyst coverage of Vitrolife

Vitrolife is a company of high quality and significant growth
opportunities still remain. With an outstanding track record, the bar
is set high, and offers little room for disappointment. We resume
coverage with a fair value (base case) of SEK 620 per share,
indicating no upside at current levels. Read more and download the
extended Research Update by Arvid Necander:

Start following Vitrolife at Redeye to instantly receive our latest
company research.

This is a press release from Redeye - Research Powered Investment


Författare Cision

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.